Pyrazole derivatives as p38 kinase inhibitors

Details Pyrazole derivatives as p38 kinase inhibitors Pyrazole derivatives as p38 kinase inhibitors

2005-02-08

2005-02-08

Stockton, Laura L. (Department: 1626)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

C546S275400, C546S276100

Reexamination Certificate

active

06852740

ABSTRACT:
A class of pyrazole derivatives is described for use in treating p38 kinase mediated disorders. Compounds of particular interest are defined by Formula Iwherein Q, R1, R2, R3and R4are as described in the specification.

REFERENCES:
patent: 3254093 (1966-05-01), Huisgen et al.
patent: 3984431 (1976-10-01), Guérémy et al.
patent: 4000281 (1976-12-01), Beiler et al.
patent: 5051518 (1991-09-01), Murray et al.
patent: 5134142 (1992-07-01), Matsuo et al.
patent: 5466823 (1995-11-01), Talley et al.
patent: 5486534 (1996-01-01), Lee et al.
patent: 5559137 (1996-09-01), Adams et al.
patent: 5589439 (1996-12-01), Goto et al.
patent: 5658903 (1997-08-01), Adams et al.
patent: 5739143 (1998-04-01), Adams et al.
patent: 5756529 (1998-05-01), Isakson et al.
patent: 5972972 (1999-10-01), Mihelich et al.
patent: 5998425 (1999-12-01), Adams et al.
patent: 6087381 (2000-07-01), Hanson et al.
patent: 295 374 (1991-10-01), None
patent: 0 115 640 (1983-12-01), None
patent: 0 418 845 (1991-03-01), None
patent: 0 515 041 (1992-11-01), None
patent: 0 531 901 (1993-03-01), None
patent: 0 846 686 (1998-06-01), None
patent: 0 846 687 (1998-06-01), None
patent: 4-145081 (1992-05-01), None
patent: 5-17470 (1993-01-01), None
patent: 5-345772 (1993-12-01), None
patent: 8-183787 (1996-07-01), None
patent: WO 8300330 (1983-02-01), None
patent: WO 9219615 (1992-11-01), None
patent: WO 9419350 (1994-09-01), None
patent: WO 9506036 (1995-03-01), None
patent: WO 9522545 (1995-08-01), None
patent: WO 9531451 (1995-11-01), None
patent: WO 9603385 (1996-02-01), None
patent: WO 9621452 (1996-07-01), None
patent: WO 9621654 (1996-07-01), None
patent: WO 9640143 (1996-12-01), None
patent: WO 9701551 (1997-01-01), None
patent: WO 9723479 (1997-07-01), None
patent: WO 9725046 (1997-07-01), None
patent: WO 9725047 (1997-07-01), None
patent: WO 9725048 (1997-07-01), None
patent: WO 9732583 (1997-09-01), None
patent: WO 9735855 (1997-10-01), None
patent: WO 9735856 (1997-10-01), None
patent: WO 9747618 (1997-12-01), None
patent: WO 9807425 (1998-02-01), None
patent: WO 9816230 (1998-04-01), None
patent: WO 9825619 (1998-06-01), None
patent: WO 9852940 (1998-11-01), None
patent: WO 9852941 (1998-11-01), None
patent: WO 9852937 A2 (1998-11-01), None
patent: WO 9857966 (1998-12-01), None
patent: WO 9901130 (1999-01-01), None
patent: WO 9901131 (1999-01-01), None
patent: WO 9901136 (1999-01-01), None
patent: WO 9901452 (1999-01-01), None
patent: WO 9917776 (1999-04-01), None
patent: WO 9932121 (1999-07-01), None
patent: WO 9961426 (1999-12-01), None
Zhengming, Li et al., “Synthesis of Di-heterocyclic Compounds; Pyrazolylimidazoles and Isoxazolylimadazoles”, Heteroatom. Chem., vol. 9, No. 3, pp. 317-320, 1998.
Zheng-Nian Huang, “Synthesis and Biological Activities of 1-(substituted pyrazol-4-yl)-1,2,4-triazoles”, Chemical Abstracts, vol. 124, No. 23, Abstract No. 317062d, 1996.
Zheng-Nian Huang, “The Reaction of α-OXO-α Triazolyketene Dithioacetal with Amines, Hydrazine and Cuanidine”, Chinese Chemical Letters, vol. 5, No. 1, pp. 31-34, 1994.
Adams, J.L. et al., “Pyrimidinylimidazole Inhibitors of CSBP/p38 Kinase Demonstrating Decreased Inhibition of Hepatic Cytochrome p450 Enzymes”, Bioorganic & Medicinal Chemistry Letters, vol. 8, pp. 3111-3116, 1998.
Badger, Alison M. et al., “Disease-Modifying Activity of SB 242235, A Selective Inhibitor of p38 Mitogen-Activated Protein Kinase, In Rat Adjuvant-Induced Arthritis”, Arthritis & Rheumatism, vol. 43, No. 1, pp. 175-183, 2000.
Bauer, V.J. et al., “4-3(5)-Pyrazolyl Pyridinium Salts. A New Class of Hypoglycemic Agents”, J. Med. Chem., vol. 11, pp. 981-984, (Sep. 1968).
Boehm, J.C. et al., “New Inhibitors Of p38 Kinase”, Exp. Opin. Ther. Patents, vol.10(1), pp. 25-36, 2000.
Cativiela, C. et al., “On the Synthesis of 3(5)-(Carbomethoxy)-4-hetarylpyrazoles”, J. Heterocycl. Chem., vol. 25, pp. 851-855, (May-Jun. 1988).
Dannhardt G. et al., “ω-Aminopropyl-pyrazole durch Ringtransformation von Enaminonen der Pyrrolidinreihe”, Arch. Pharm., vol. 321, No. 1, pp. 17-19, 1988.
Fischer, U. et al., “1,3-Dipolar Additions To 7-Methylthieno[2,3-c]pyridine 1,1-dioxide”, Helv. Chim. Acta, vol. 63(6), No. 180, pp. 1719-1727, 1980.
Gallagher, T.F., “Regulation of Stress-Induced Cytokine Production By Pyridinylimidazoles; Inhibition of CSBP Kinase”, Bioorganic & Medicinal Chemistry, vol. 5, pp. 49-64, 1997.
Hanson, G.J., “Pulmonary-Allergy, Dermatological, Gastrointestinal&Arthritis”, Exp. Opin. Ther. Patents, vol. 7, pp. 729-733, 1997.
Henry, James R., “p38 Mitogen-Activated Protein Kinase as a Target for Drug Discovery”, Drugs of the Future, vol. 24, pp. 1345-1354, 1999.
Laszlo, S.E. et al., “Pyrroles and Other Heterocycles as Inhibitors of p38 Kinase”, Bioorganic & Medicinal Chemistry Letters 8, pp. 2689-2694, 1998.
Liverton, N.J. et al., “Design and Synthesis of Potent, Selective and Orally Bioavailable Tetrasubstituted Imidazole Inhibitors of p38 Kinase Mitogen-Activated Protein Kinase”, J. Med. Chem., vol. 42, pp. 2180-2190, 1999.
Moerck, R.E. et al., “Pyrazole Addition to Δ1-Azirines. Structure of Purported 2:1 Adducts of Δ1-Azirines With sym-Tetrazines”, J. Chem. Soc., Chem. Commun., No. 19, pp. 782-783, 1974.
PCT International Search Report (PCT/US98/10436) Sep. 24, 1998.
Popova, A.N. et al., “Synthesis of 4-(Pyrazol-4-yl)-Substituted Salts of Pyrylium and Pyridines”, Chemical Abstracts, vol. 098, No. 1, Jan. 3, 1983, Abstract No. 004498.
Salituro, F.G. et al., “Inhibitors of p38 MAP Kinase: Therapeutic Intervention Cytokine-Mediated Diseases”, Current Medicinal Chemistry, Issue 6, pp. 807-823, 1999.

Affiliated with

Also associated with

Rating

Pyrazole derivatives as p38 kinase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Pyrazole derivatives as p38 kinase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pyrazole derivatives as p38 kinase inhibitors will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3473283